David Rogers, MD
Ophthalmology · Columbus, OHNPI 1326076647
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,735 of the $8,891 with a category attached, or 98.3%. Biomarin Pharmaceutical Inc. accounts for 84.3% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $6,916, 9.9 times the $700 reported in 2020. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $683.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$7K
- Amicus Therapeutics, Inc.$1K
Across 18 payments — averaging $80,844 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$1.5M
What the payments were for
- Consulting fees$8,73598%
- Food & beverage$1552%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 9 | $7,491 |
| Amicus Therapeutics, Inc. | 4 | $1,400 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GALAFOLD$700
How this compares
$8,891 in reported general payments places this provider in the 90th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Columbus
- Alice EpitropoulosColumbus$531K
- Steven KatzColumbus$256K
- David LehmannColumbus$58K
- Lisa BorkowskiColumbus$25K
- Thomas MendelColumbus$15K
- Norman BakerColumbus$11K
- Carrie LembachColumbus$11K
- John ChristoforidisColumbus$10K
- Peter KaiserCleveland$1.5M
- Gregory EippertMentor$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.